Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating activities
Net income (loss)	$ (22,156)	$ 2,748
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities	20,844	8,657
Net cash provided by (used in) operating activities	(1,312)	11,405
Investing activities
Purchases of fixed income and equity securities	(82,641)	(140,645)
Purchases of limited partnership interests	0	0
Distributions from limited partnerships	14,636	17,214
Proceeds from maturities	31,088	16,776
Proceeds from sales of fixed income securities	48,552	52,199
Proceeds from sales of equity securities	5,480	9,169
Purchase of insurance company-owned life insurance	0	0
Purchase of commercial mortgage loans	(368)	(1,172)
Proceeds from commercial mortgage loans	72	0
Purchases of property and equipment	(369)	(797)
Proceeds from disposals of property and equipment	0	0
Net cash provided by (used in) investing activities	16,450	(47,256)
Financing activities
Dividends paid to shareholders	(1,426)	(1,493)
Repurchase of common shares	(1,782)	(468)
Net cash used in financing activities	(3,208)	(1,961)
Effect of foreign exchange rates on cash and cash equivalents	(687)	307
Increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents	11,243	(37,505)
Cash, cash equivalents and restricted cash and cash equivalents at beginning of period	88,888	170,811
Cash, cash equivalents and restricted cash and cash equivalents at end of period	$ 100,131	$ 133,306